Literature DB >> 3181443

Reduction of oral toxicity of 5-fluorouracil by allopurinol mouthwashes.

N Tsavaris1, P Caragiauris, P Kosmidis.   

Abstract

5-Fluorouracil (5-FU) is the most effective drug in gastrointestinal cancer. Mucositis and bone marrow toxicity are the two major limiting side effects. In our effort to reduce mucositis we administered 'Allopurinol' mouthwash in 16 patients who had experienced oral mucositis during prior treatment with 5-FU. In all patients significant reduction of oral toxicity was noticed as well as prolonged pain relief. This observation must be tested by controlled clinical trial.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3181443

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  3 in total

Review 1.  Systematic review of miscellaneous agents for the management of oral mucositis in cancer patients.

Authors:  Siri Beier Jensen; Virginia Jarvis; Yehuda Zadik; Andrei Barasch; Anura Ariyawardana; Allan Hovan; Noam Yarom; Rajesh V Lalla; Joanne Bowen; Sharon Elad
Journal:  Support Care Cancer       Date:  2013-07-31       Impact factor: 3.603

Review 2.  Cancer therapy and oral mucositis. An appraisal of drug prophylaxis.

Authors:  C J Verdi
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

3.  Alteration of the redox state with reactive oxygen species for 5-fluorouracil-induced oral mucositis in hamsters.

Authors:  Fumihiko Yoshino; Ayaka Yoshida; Atsushi Nakajima; Satoko Wada-Takahashi; Shun-suke Takahashi; Masaichi Chang-il Lee
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.